2 June 2026
Latham Advises the Banks on Biogroup’s €3 Billion Refinancing
Advising firms
Deal team
7 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Lionel Dechmann Lead | Latham & Watkins LLP | Partner | finance | Paris |
| Thomas Margenet-Baudry Lead | Latham & Watkins LLP | Partner | Capital Markets | Paris |
| Virginie Terzic | Latham & Watkins LLP | Counsel | finance | Paris |
| Michael Ettannani | Latham & Watkins LLP | Counsel | Capital Markets | Paris |
| Lucie Boiteux | Latham & Watkins LLP | Associate | finance | Paris |
| Ophélie Emprin | Latham & Watkins LLP | Associate | finance | Paris |
| Madeleine Hahn de Bykhovetz | Latham & Watkins LLP | Associate | Capital Markets | Paris |
4 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- EUR 3bn (€3 Billion)
- What the figure measures
- Total transaction value
- Client
- Not stated
- Counterparties
- Biogroup (Borrower)